SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
23-Jan-24 8:38 PM View: | Mirati Therapeutics, Inc. (MRTX) | 23-Jan-24 | Disposition | 11,252 | -- | -- | (100%) 11.25K to 0 | |
03-Jan-24 6:22 PM View: | Mirati Therapeutics, Inc. (MRTX) | 29-Dec-23 | Grant | 6,808 | $58.75 | $399,970.00 | 153% 4.44K to 11.25K | |
24-Jan-23 4:18 PM View: | Mirati Therapeutics, Inc. (MRTX) | 20-Jan-23 | Grant | 4,444 | -- | -- | 100% 0 to 4.44K | |
20-Jan-23 9:20 AM View: | Mirati Therapeutics, Inc. (MRTX) | 18-Jan-23 | Sale (Planned) | 2,546 | $44.66 | $113,704.00 | (100%) 2.55K to 0 | |
08-Aug-22 6:22 PM View: | Nabi Biopharmaceuticals (VXRT) | 04-Aug-22 | Grant | 6,217 | -- | -- | 100% 0 to 6.22K | |
20-Jan-22 4:57 PM View: | Mirati Therapeutics, Inc. (MRTX) | 19-Jan-22 | Market Sale (Planned) | 1,475 | $116.07 | $171,203.00 | (37%) 4.02K to 2.55K | (7%) |
18-Jan-22 6:19 PM View: | Mirati Therapeutics, Inc. (MRTX) | 14-Jan-22 | Grant | 2,546 | -- | -- | 173% 1.48K to 4.02K | |
04-Mar-21 5:25 PM View: | Mirati Therapeutics, Inc. (MRTX) | 02-Mar-21 | Market Sale | 2,000 | $201.01 | $402,020.00 | (58%) 3.48K to 1.48K | 6% |
20-Jan-21 6:15 PM View: | Mirati Therapeutics, Inc. (MRTX) | 15-Jan-21 | Grant | 1,475 | -- | -- | 74% 2.0K to 3.48K | |
07-Jan-20 8:30 PM View: | Mirati Therapeutics, Inc. (MRTX) | 03-Jan-20 | Grant | 2,000 | -- | -- | 100% 0 to 2.0K |